Concepedia

Risk factors for chemotherapy‐induced nausea in pediatric patients receiving highly emetogenic chemotherapy

L. Lee Dupuis, Roy Tamura, Kara M. Kelly, Jeffrey P. Krischer, Anne‐Marie Langevin, Lu Chen, E. Anders Kolb, Nicole J. Ullrich, Olle Jane Z. Sahler, Eleanor Hendershot,

Pediatric Blood & Cancer · 2018 · 21 citations · 14 references

DOI

Abstract

Acute phase CIN was associated with nonwhite race. Delayed phase CIN was associated with poor acute phase CIN control, diagnosis of non-CNS cancer, and receipt of cisplatin. These findings will inform future antiemetic trial design.

References

14

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

Paul J. Hesketh, Matti Aapro, James C. Street et al. · Supportive Care in Cancer · 2009 · 169 citations

, , +12

Risk factors of chemotherapy‐induced nausea and vomiting: Index for personalized antiemetic prophylaxis

Ikuo Sekine, Yoshihiko Segawa, Kaoru Kubota et al. · Cancer Science · 2013 · 165 citations · Full text

, , +21

Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study

Alex Molassiotis, Matti Aapro, Mario Dicato et al. · Journal of Pain and Symptom Management · 2013 · 152 citations · Full text

, , +7

Development and Validation of a Pictorial Nausea Rating Scale for Children

Amy L. Baxter, Mehernoor F. Watcha, William Baxter et al. · PEDIATRICS · 2011 · 143 citations

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy

David Warr, James C. Street, Alexandra D. Carides · Supportive Care in Cancer · 2010 · 123 citations

, , +12